miR‐17‐3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN inhibition

Multiple myeloma (MM), a hematological malignancy, has a poor prognosis and requires an invasive procedure. Reports have implicated miRNAs in the diagnosis, treatment and prognosis of hematological malignancies. In our study, we evaluated the expression profiles of miR‐17‐3p in plasma and bone marro...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Pu, Yeung, Yiu To, Wang, Jiheng, Wu, Qiong, Du, Ruijuan, Huang, Chuntian, Jia, Xuechao, Gao, Yunfeng, Zhi, Yafei, Guo, Fangqin, Wei, Huifang, Zhang, Dandan, Liu, Yuzhang, Liu, Lina, Liang, Lijie, Wang, Juan, Song, Yongping, Liu, Kangdong, Fang, Baijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Molecular Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248421/
https://www.ncbi.nlm.nih.gov/pubmed/33609405
http://dx.doi.org/10.1002/ijc.33528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248421/
https://www.ncbi.nlm.nih.gov/pubmed/33609405
http://dx.doi.org/10.1002/ijc.33528

Ejemplares similares